{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:13:49Z","timestamp":1790723629420,"version":"4.1.0"},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,6,1]]},"DOI":"10.2169\/internalmedicine.9670-22","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T22:25:43Z","timestamp":1665527143000},"page":"1659-1663","source":"Crossref","is-referenced-by-count":2,"title":["Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2"],"prefix":"10.2169","volume":"62","author":[{"given":"Aki","family":"Murayama","sequence":"first","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Sugaya","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hara","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Kawazoe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Tobisawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Nihon University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 133: 2734-2748, 2010.","DOI":"10.1093\/brain\/awq213"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR. LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry 89: 526-534, 2018.","DOI":"10.1136\/jnnp-2017-315720"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. van Sonderen A, Ari\u00f1o H, Petit-Pedrol M, et al. The clinical spectrum of Caspr2 antibody-associated disease. Neurology 87: 521-528, 2016.","DOI":"10.1212\/WNL.0000000000002917"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15: 391-404, 2016.","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. van Sonderen A, Mar Petit-Pedrol, Josep Dalmau, Maarten JTitulaer. The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol 13: 290-301, 2017.","DOI":"10.1038\/nrneurol.2017.43"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Hara M, Martinez-Hernandez E, Ari\u00f1o H, et al. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor. Neurology 90: e1386-e1394, 2018.","DOI":"10.1212\/WNL.0000000000005329"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. van Sonderen A, Thijis RD, Coenders EC, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology 87: 1449-1456, 2016.","DOI":"10.1212\/WNL.0000000000003173"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lehmann-Horn K, Irani SR, Wang S, et al. Intrathecal B-cell activation in LGI1 antibody encephalitis. Neurol Neuroimmunol Neuroinflamm 7: e669, 2020.","DOI":"10.1212\/NXI.0000000000000669"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. von B\u00fcdingen HC, Kuo TC, Sirota M, et al. B cell exchange across the blood-brain barrier in multiple sclerosis. J Clin Invest 122: 4533-4543, 2012.","DOI":"10.1172\/JCI63842"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Head K, Gong S, Joseph S, et al. Defining the expression pattern of the LGI1 gene in BAC transgenic mice. Mamm Genome 18: 328-337, 2007.","DOI":"10.1007\/s00335-007-9024-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Saint-Martin M, Joubert B, Pellier-Monnin V, Pascual O, Noraz N, Honnorat J. Contactin-associated protein-like 2, a protein of the neurexin family involved in several human diseases. Eur J Neurosci 48: 1906-1923, 2018.","DOI":"10.1111\/ejn.14081"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Carson MJ. Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia 40: 218-231, 2002.","DOI":"10.1002\/glia.10145"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/11\/62_9670-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T03:33:34Z","timestamp":1685763214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/11\/62_9670-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9670-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"article-number":"9670-22"}}